Neuronal mdr-1 gene expression after experimental focal hypoxia: A new obstacle for neuroprotection?
Neuronal mdr-1 gene expression after experimental focal hypoxia: A new obstacle for neuroprotection?
复制标题
DOI:
10.1016/j.jns.2007.03.004
复制
发表时间:
2007-07-15
影响因子:
4.4
通讯作者:
Brusco, Alicia
中科院分区:
文献类型:
--
作者:
Lazarowski, Alberto;Caltana, Laura;Brusco, Alicia
Neuronal damage after stroke-associated brain hypoxia is a leading cause of long-term disability and death. The refractoriness to therapeutic strategies for neuroprotection after 3 h post brain ischemia is poorly understood. P-glycoprotein (P-gp), the multidrug resistance gene (MDR-1) product is normally expressed at blood-brain-barrier. P-gp neuronal expression has been demonstrated in refractory epilepsy and after brain ischemia. In this report we investigated the hypoxia-induced neuronal P-gp expression after local injection of CoCl2 (1-200 mM) in the frontoparietal cortex of male adult rats (Bregma - 1.30 mm) by stereotaxic surgery. P-gp immunostaining of brain slides was analyzed using specific monoclonal antibodies and double immunolabeling was done with specific astrocytic and neuronal markers. Five days after injection of 1 mM CoCl2, P-gp expression surrounding the lesion site was observed in neurons, astrocytic end-foot on capillary blood vessels and endothelial cells on blood vessels. Higher CoCl2 doses (200 mM) resulted in additional P-gp immunostaining of the entire astrocytic and neuronal cytoplasm. Electron microscopy (EM) studies showed alterations in neurons as early as 6 h after the CoCl2, injection. P-gp expression in hypoxic neurons and astrocytic end-foot could potentially impair of drugs access to the brain parenchyma thus suggesting the presence of two P-gp-based pumping systems (one in astrocytes and other in the hypoxic neurons) that are able to behave as a previously unnoticed obstacle for pharmacological strategies of neuroprotection. (c) 2007 Elsevier B.V. All rights reserved.